Type 2 Diabetes and Pregnancy a Single-arm Interventional Study

This single-arm interventional study evaluates the MiniMed 780G insulin pump and continuous glucose monitoring (CGM) system in pregnant women with type 2 diabetes enrolled at ≤ 16 weeks gestation. From recruitment to delivery, participants attend regular clinical visits for active insulin adjustments. The primary objective is to measure the percentage of time spent in the target pregnancy glucose range (63-140 mg/dL). Secondary outcomes track mean glucose, HbA1c, and overall maternal and neonatal health to ensure safety and efficacy.

NCT Number	NCT07602036
Lead Sponsor	Poznan University of Medical Sciences Collaborators: Medtronic
Conditions	Pregnancy, Type 2 Diabetes
Enrollment	20 participants
Start Date	2026-05-01
Primary Completion	2028-10 (estimated)
Study Completion	2029-02 (estimated)
Updated on ClinicalTrials.gov	2026-05-22